University Hospital of Umeå, in Swedish Norrlands universitetssjukhus, is the major hospital in northern Sweden, situated in Umeå. The hospital employs 5,600 people.

During the past decade, Department of Clinical Sciences, Pediatrics, Umeå University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital" are "Leukemia, Acute Lymphoblastic" (2 trials), "Acute Gastroenteritis" (1 trials), "Dietary Supplements" (1 trials), "Food, Fortified" (1 trials) and "Infant" (1 trials). Many other conditions were trialed in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital" are "Dietary Supplement" (4 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Blinatumomab" (1 trials), "Imatinib" (1 trials), "Inotuzumab Ozogamicin+Standard Maintenance Therapy" (1 trials) and "Lactobacillus reuteri DSM 17938 and zinc sulphate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Clinical Sciences, Pediatrics, Umeå University Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Clinical Sciences, Pediatrics, Umeå University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Sciences, Pediatrics, Umeå University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".